What Is Non Invasive Prenatal Testing?

Learn what non invasive prenatal testing (NIPT) is, how cell‑free DNA screening works, and why it's a trusted first step for US parents in 2026.

Non invasive prenatal testing (NIPT) is a blood‑based screening that analyzes cell‑free DNA from the placenta to assess the risk of common chromosomal conditions such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13. Unlike diagnostic procedures like chorionic villus sampling or amniocentesis, NIPT poses no risk to the pregnancy because it requires only a maternal blood draw. In 2026, NIPT is recommended by major US medical societies as a first‑line screening option for all pregnant individuals, regardless of age, and is often covered by insurance when ordered by a healthcare provider.

How Non Invasive Prenatal Testing Works

NIPT, also called cell‑free DNA screening, isolates small fragments of DNA that circulate in the mother’s bloodstream. These fragments come from both the mother and the placenta. By sequencing and counting these fragments, the test can detect an excess or deficit of specific chromosomes. The accuracy of NIPT for the most common trisomies exceeds 99%, though it remains a screening test—not a diagnosis. Positive results should be confirmed with chorionic villus sampling or amniocentesis, and a genetic counselor can help interpret results.

The Role of Fetal Fraction

A key factor in NIPT reliability is the fetal fraction—the proportion of cell‑free DNA that originates from the placenta. Most labs require a fetal fraction of at least 3‑4% to report results. Factors such as maternal weight, gestational age, and multiple gestations can affect fetal fraction. If the fraction is too low, the lab may request a redraw after a week or two.

What NIPT Screens For

In 2026, standard NIPT panels screen for:

Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Sex chromosome aneuploidies (e.g., Turner syndrome, Klinefelter syndrome)
Fetal sex (optional, often included)

Some expanded NIPT options also screen for microdeletions, such as 22q11.2 deletion syndrome (DiGeorge syndrome). However, the positive predictive value for these rarer conditions is lower, so pre‑test counseling is essential.

NIPT vs. Other Prenatal Screening Options

US patients often encounter multiple screening pathways. The table below compares NIPT with other common tests.

Test	Timing	What It Measures	Risk
NIPT (cell‑free DNA)	From 10 weeks	Placental DNA fragments	None (blood draw)
First‑trimester screening	11–14 weeks	Ultrasound + blood markers (PAPP‑A, hCG)	None
Quad screen	15–22 weeks	Four maternal serum markers	None
Integrated screening	First + second trimester	Combined results from both trimesters	None
Carrier screening	Any time (ideally pre‑conception)	DNA for recessive conditions (e.g., CF, SMA, fragile X)	None

While NIPT has the highest detection rate for the common trisomies, it does not replace carrier screening or a detailed anatomy ultrasound. Many US providers offer integrated care where NIPT is combined with carrier screening and first‑trimester screening for a comprehensive view.

When to Consider NIPT

NIPT is appropriate for any pregnant person who wants early information about chromosomal health. The American College of Obstetricians and Gynecologists (ACOG) now recommends that all patients be offered NIPT regardless of age or baseline risk. Because it is a screening test, results are reported as “high risk” or “low risk.” A high‑risk result does not mean the baby has a condition—it means further diagnostic testing is recommended. A genetic counselor can guide you through next steps, including the option of chorionic villus sampling (CVS) or amniocentesis.

NIPT and Multiple Pregnancies

NIPT can be used in twin and triplet pregnancies, though accuracy may be slightly lower. Some labs require a separate blood draw or adjust algorithms for multiples. Discuss with your provider which lab best supports your situation.

How to Order a Prenatal Screening Panel

Understanding what non invasive prenatal testing is helps you make an informed decision about your prenatal care. After reviewing your options, the next step is to choose a comprehensive screening panel that fits your needs. Many US patients now order their NIPT and carrier screening together to maximize early information. You can order a prenatal screening panel online, receive a simple blood draw kit, and get results in about 7–10 business days. Order a prenatal screening panel online and take control of your pregnancy journey with trusted, accurate screening.